nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Lomustine—hematologic cancer	0.0507	0.0738	CbGbCtD
Dihydrocodeine—CYP2D6—Idarubicin—hematologic cancer	0.0452	0.0658	CbGbCtD
Dihydrocodeine—CYP2D6—Hydroxyurea—hematologic cancer	0.0384	0.0559	CbGbCtD
Dihydrocodeine—CYP3A4—Bexarotene—hematologic cancer	0.0347	0.0505	CbGbCtD
Dihydrocodeine—CYP2D6—Bortezomib—hematologic cancer	0.0334	0.0487	CbGbCtD
Dihydrocodeine—CYP3A4—Lomustine—hematologic cancer	0.0323	0.0469	CbGbCtD
Dihydrocodeine—CYP3A4—Busulfan—hematologic cancer	0.0323	0.0469	CbGbCtD
Dihydrocodeine—CYP3A4—Thiotepa—hematologic cancer	0.0287	0.0418	CbGbCtD
Dihydrocodeine—CYP2D6—Imatinib—hematologic cancer	0.0245	0.0357	CbGbCtD
Dihydrocodeine—CYP3A4—Methoxsalen—hematologic cancer	0.0224	0.0325	CbGbCtD
Dihydrocodeine—CYP2D6—Nilotinib—hematologic cancer	0.0223	0.0324	CbGbCtD
Dihydrocodeine—CYP2D6—Vinorelbine—hematologic cancer	0.0221	0.0321	CbGbCtD
Dihydrocodeine—CYP3A4—Bortezomib—hematologic cancer	0.0213	0.0309	CbGbCtD
Dihydrocodeine—CYP3A4—Daunorubicin—hematologic cancer	0.0203	0.0296	CbGbCtD
Dihydrocodeine—CYP3A4—Cytarabine—hematologic cancer	0.0179	0.0261	CbGbCtD
Dihydrocodeine—CYP3A4—Teniposide—hematologic cancer	0.0177	0.0257	CbGbCtD
Dihydrocodeine—CYP3A4—Ifosfamide—hematologic cancer	0.0163	0.0237	CbGbCtD
Dihydrocodeine—CYP3A4—Imatinib—hematologic cancer	0.0156	0.0227	CbGbCtD
Dihydrocodeine—CYP3A4—Ruxolitinib—hematologic cancer	0.0147	0.0213	CbGbCtD
Dihydrocodeine—CYP3A4—Nilotinib—hematologic cancer	0.0142	0.0206	CbGbCtD
Dihydrocodeine—CYP3A4—Vinorelbine—hematologic cancer	0.014	0.0204	CbGbCtD
Dihydrocodeine—CYP2D6—Vinblastine—hematologic cancer	0.0136	0.0198	CbGbCtD
Dihydrocodeine—CYP3A4—Triamcinolone—hematologic cancer	0.0128	0.0187	CbGbCtD
Dihydrocodeine—CYP3A4—Dasatinib—hematologic cancer	0.0125	0.0182	CbGbCtD
Dihydrocodeine—CYP3A4—Mitoxantrone—hematologic cancer	0.0124	0.018	CbGbCtD
Dihydrocodeine—CYP3A4—Betamethasone—hematologic cancer	0.011	0.016	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisolone—hematologic cancer	0.0109	0.0158	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—hematologic cancer	0.0103	0.0149	CbGbCtD
Dihydrocodeine—CYP2D6—Dexamethasone—hematologic cancer	0.0101	0.0147	CbGbCtD
Dihydrocodeine—CYP3A4—Irinotecan—hematologic cancer	0.00973	0.0142	CbGbCtD
Dihydrocodeine—CYP3A4—Vinblastine—hematologic cancer	0.00865	0.0126	CbGbCtD
Dihydrocodeine—CYP3A4—Vincristine—hematologic cancer	0.00851	0.0124	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—hematologic cancer	0.00836	0.0122	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—hematologic cancer	0.00779	0.0113	CbGbCtD
Dihydrocodeine—CYP3A4—Dexamethasone—hematologic cancer	0.00641	0.00932	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—hematologic cancer	0.00532	0.00774	CbGbCtD
Dihydrocodeine—Morphine—UGT1A1—hematologic cancer	0.0005	0.413	CrCbGaD
Dihydrocodeine—Codeine—SLC22A1—hematologic cancer	0.000497	0.41	CrCbGaD
Dihydrocodeine—Diarrhoea—Carmustine—hematologic cancer	0.000139	0.000511	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—hematologic cancer	0.000139	0.000511	CcSEcCtD
Dihydrocodeine—Nausea—Bleomycin—hematologic cancer	0.000139	0.000509	CcSEcCtD
Dihydrocodeine—Rash—Thiotepa—hematologic cancer	0.000138	0.000507	CcSEcCtD
Dihydrocodeine—Dermatitis—Thiotepa—hematologic cancer	0.000138	0.000507	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000138	0.000507	CcSEcCtD
Dihydrocodeine—Diarrhoea—Alitretinoin—hematologic cancer	0.000138	0.000507	CcSEcCtD
Dihydrocodeine—Convulsion—Betamethasone—hematologic cancer	0.000138	0.000505	CcSEcCtD
Dihydrocodeine—Convulsion—Dexamethasone—hematologic cancer	0.000138	0.000505	CcSEcCtD
Dihydrocodeine—Headache—Thiotepa—hematologic cancer	0.000137	0.000504	CcSEcCtD
Dihydrocodeine—Diarrhoea—Ifosfamide—hematologic cancer	0.000136	0.000501	CcSEcCtD
Dihydrocodeine—Nausea—Vinorelbine—hematologic cancer	0.000136	0.0005	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000136	0.000499	CcSEcCtD
Dihydrocodeine—Vomiting—Thalidomide—hematologic cancer	0.000135	0.000495	CcSEcCtD
Dihydrocodeine—Dizziness—Carmustine—hematologic cancer	0.000135	0.000494	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—hematologic cancer	0.000135	0.000494	CcSEcCtD
Dihydrocodeine—Rash—Thalidomide—hematologic cancer	0.000134	0.000491	CcSEcCtD
Dihydrocodeine—Dermatitis—Thalidomide—hematologic cancer	0.000134	0.00049	CcSEcCtD
Dihydrocodeine—Dizziness—Alitretinoin—hematologic cancer	0.000133	0.00049	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vincristine—hematologic cancer	0.000133	0.000488	CcSEcCtD
Dihydrocodeine—Headache—Thalidomide—hematologic cancer	0.000133	0.000487	CcSEcCtD
Dihydrocodeine—Dizziness—Ifosfamide—hematologic cancer	0.000132	0.000484	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—hematologic cancer	0.000131	0.000481	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—hematologic cancer	0.000131	0.00048	CcSEcCtD
Dihydrocodeine—Pruritus—Gemcitabine—hematologic cancer	0.000131	0.000479	CcSEcCtD
Dihydrocodeine—Nausea—Thiotepa—hematologic cancer	0.00013	0.000478	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—hematologic cancer	0.00013	0.000478	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—hematologic cancer	0.00013	0.000476	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mitoxantrone—hematologic cancer	0.00013	0.000475	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irinotecan—hematologic cancer	0.00013	0.000475	CcSEcCtD
Dihydrocodeine—Vomiting—Carmustine—hematologic cancer	0.00013	0.000475	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—hematologic cancer	0.000129	0.000473	CcSEcCtD
Dihydrocodeine—Dizziness—Vincristine—hematologic cancer	0.000129	0.000472	CcSEcCtD
Dihydrocodeine—Rash—Carmustine—hematologic cancer	0.000128	0.000471	CcSEcCtD
Dihydrocodeine—Dermatitis—Carmustine—hematologic cancer	0.000128	0.000471	CcSEcCtD
Dihydrocodeine—Vomiting—Alitretinoin—hematologic cancer	0.000128	0.000471	CcSEcCtD
Dihydrocodeine—Paraesthesia—Triamcinolone—hematologic cancer	0.000128	0.000471	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisolone—hematologic cancer	0.000128	0.00047	CcSEcCtD
Dihydrocodeine—Headache—Carmustine—hematologic cancer	0.000128	0.000468	CcSEcCtD
Dihydrocodeine—Dyspnoea—Triamcinolone—hematologic cancer	0.000127	0.000467	CcSEcCtD
Dihydrocodeine—Rash—Alitretinoin—hematologic cancer	0.000127	0.000467	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Dexamethasone—hematologic cancer	0.000127	0.000466	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Betamethasone—hematologic cancer	0.000127	0.000466	CcSEcCtD
Dihydrocodeine—Dermatitis—Alitretinoin—hematologic cancer	0.000127	0.000466	CcSEcCtD
Dihydrocodeine—Vomiting—Ifosfamide—hematologic cancer	0.000127	0.000465	CcSEcCtD
Dihydrocodeine—Headache—Alitretinoin—hematologic cancer	0.000126	0.000464	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—hematologic cancer	0.000126	0.000464	CcSEcCtD
Dihydrocodeine—Diarrhoea—Gemcitabine—hematologic cancer	0.000126	0.000463	CcSEcCtD
Dihydrocodeine—Nausea—Thalidomide—hematologic cancer	0.000126	0.000462	CcSEcCtD
Dihydrocodeine—Rash—Ifosfamide—hematologic cancer	0.000126	0.000461	CcSEcCtD
Dihydrocodeine—Dermatitis—Ifosfamide—hematologic cancer	0.000126	0.000461	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000125	0.00046	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000125	0.00046	CcSEcCtD
Dihydrocodeine—Dizziness—Irinotecan—hematologic cancer	0.000125	0.000459	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—hematologic cancer	0.000125	0.000459	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—hematologic cancer	0.000125	0.000457	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—hematologic cancer	0.000124	0.000456	CcSEcCtD
Dihydrocodeine—Vomiting—Vincristine—hematologic cancer	0.000124	0.000454	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisolone—hematologic cancer	0.000123	0.000453	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—hematologic cancer	0.000123	0.00045	CcSEcCtD
Dihydrocodeine—Rash—Vincristine—hematologic cancer	0.000123	0.00045	CcSEcCtD
Dihydrocodeine—Dermatitis—Vincristine—hematologic cancer	0.000123	0.000449	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—hematologic cancer	0.000122	0.000447	CcSEcCtD
Dihydrocodeine—Headache—Vincristine—hematologic cancer	0.000122	0.000447	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—hematologic cancer	0.000121	0.000444	CcSEcCtD
Dihydrocodeine—Hypotension—Betamethasone—hematologic cancer	0.000121	0.000444	CcSEcCtD
Dihydrocodeine—Hypotension—Dexamethasone—hematologic cancer	0.000121	0.000444	CcSEcCtD
Dihydrocodeine—Nausea—Carmustine—hematologic cancer	0.000121	0.000444	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—hematologic cancer	0.000121	0.000442	CcSEcCtD
Dihydrocodeine—Vomiting—Mitoxantrone—hematologic cancer	0.00012	0.000442	CcSEcCtD
Dihydrocodeine—Vomiting—Irinotecan—hematologic cancer	0.00012	0.000442	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—hematologic cancer	0.00012	0.00044	CcSEcCtD
Dihydrocodeine—Nausea—Alitretinoin—hematologic cancer	0.00012	0.00044	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisone—hematologic cancer	0.00012	0.00044	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—hematologic cancer	0.00012	0.000439	CcSEcCtD
Dihydrocodeine—Rash—Mitoxantrone—hematologic cancer	0.000119	0.000438	CcSEcCtD
Dihydrocodeine—Rash—Irinotecan—hematologic cancer	0.000119	0.000438	CcSEcCtD
Dihydrocodeine—Dermatitis—Mitoxantrone—hematologic cancer	0.000119	0.000438	CcSEcCtD
Dihydrocodeine—Dermatitis—Irinotecan—hematologic cancer	0.000119	0.000438	CcSEcCtD
Dihydrocodeine—Headache—Mitoxantrone—hematologic cancer	0.000119	0.000435	CcSEcCtD
Dihydrocodeine—Headache—Irinotecan—hematologic cancer	0.000119	0.000435	CcSEcCtD
Dihydrocodeine—Nausea—Ifosfamide—hematologic cancer	0.000118	0.000435	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000118	0.000432	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cisplatin—hematologic cancer	0.000118	0.000432	CcSEcCtD
Dihydrocodeine—Vomiting—Gemcitabine—hematologic cancer	0.000117	0.00043	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000117	0.000429	CcSEcCtD
Dihydrocodeine—Morphine—ABCB1—hematologic cancer	0.000117	0.0965	CrCbGaD
Dihydrocodeine—Paraesthesia—Dexamethasone—hematologic cancer	0.000116	0.000427	CcSEcCtD
Dihydrocodeine—Paraesthesia—Betamethasone—hematologic cancer	0.000116	0.000427	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—hematologic cancer	0.000116	0.000427	CcSEcCtD
Dihydrocodeine—Rash—Gemcitabine—hematologic cancer	0.000116	0.000427	CcSEcCtD
Dihydrocodeine—Dermatitis—Gemcitabine—hematologic cancer	0.000116	0.000426	CcSEcCtD
Dihydrocodeine—Headache—Gemcitabine—hematologic cancer	0.000116	0.000424	CcSEcCtD
Dihydrocodeine—Nausea—Vincristine—hematologic cancer	0.000116	0.000424	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000114	0.000417	CcSEcCtD
Dihydrocodeine—Urticaria—Triamcinolone—hematologic cancer	0.000114	0.000416	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—hematologic cancer	0.000113	0.000414	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—hematologic cancer	0.000113	0.000414	CcSEcCtD
Dihydrocodeine—Nausea—Mitoxantrone—hematologic cancer	0.000112	0.000413	CcSEcCtD
Dihydrocodeine—Nausea—Irinotecan—hematologic cancer	0.000112	0.000413	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—hematologic cancer	0.000112	0.000412	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—hematologic cancer	0.000112	0.000411	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000112	0.000411	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000112	0.000411	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—hematologic cancer	0.000111	0.000409	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Prednisone—hematologic cancer	0.000111	0.000406	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—hematologic cancer	0.00011	0.000402	CcSEcCtD
Dihydrocodeine—Nausea—Gemcitabine—hematologic cancer	0.00011	0.000402	CcSEcCtD
Dihydrocodeine—Vomiting—Cisplatin—hematologic cancer	0.000109	0.000401	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisone—hematologic cancer	0.000109	0.0004	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—hematologic cancer	0.000109	0.000399	CcSEcCtD
Dihydrocodeine—Rash—Cisplatin—hematologic cancer	0.000108	0.000398	CcSEcCtD
Dihydrocodeine—Dermatitis—Cisplatin—hematologic cancer	0.000108	0.000397	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—hematologic cancer	0.000108	0.000395	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Betamethasone—hematologic cancer	0.000107	0.000392	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000107	0.000392	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000106	0.000389	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000106	0.000389	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—hematologic cancer	0.000104	0.000383	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—hematologic cancer	0.000104	0.000382	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—hematologic cancer	0.000104	0.000381	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—hematologic cancer	0.000104	0.000381	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000104	0.00038	CcSEcCtD
Dihydrocodeine—Urticaria—Dexamethasone—hematologic cancer	0.000103	0.000378	CcSEcCtD
Dihydrocodeine—Urticaria—Betamethasone—hematologic cancer	0.000103	0.000378	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisolone—hematologic cancer	0.000103	0.000377	CcSEcCtD
Dihydrocodeine—Abdominal pain—Betamethasone—hematologic cancer	0.000102	0.000376	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dexamethasone—hematologic cancer	0.000102	0.000376	CcSEcCtD
Dihydrocodeine—Nausea—Cisplatin—hematologic cancer	0.000102	0.000375	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—hematologic cancer	0.000101	0.000372	CcSEcCtD
Dihydrocodeine—Pruritus—Triamcinolone—hematologic cancer	0.000101	0.000371	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—hematologic cancer	0.000101	0.00037	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—hematologic cancer	0.0001	0.000367	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—hematologic cancer	0.0001	0.000367	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—hematologic cancer	9.93e-05	0.000364	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—hematologic cancer	9.92e-05	0.000364	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—hematologic cancer	9.87e-05	0.000362	CcSEcCtD
Dihydrocodeine—Dextromethorphan—ABCB1—hematologic cancer	9.81e-05	0.081	CrCbGaD
Dihydrocodeine—Rash—Prednisolone—hematologic cancer	9.8e-05	0.000359	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisolone—hematologic cancer	9.79e-05	0.000359	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.78e-05	0.000359	CcSEcCtD
Dihydrocodeine—Headache—Prednisolone—hematologic cancer	9.73e-05	0.000357	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—hematologic cancer	9.72e-05	0.000357	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—hematologic cancer	9.66e-05	0.000354	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—hematologic cancer	9.51e-05	0.000349	CcSEcCtD
Dihydrocodeine—Dizziness—Triamcinolone—hematologic cancer	9.45e-05	0.000347	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—hematologic cancer	9.37e-05	0.000344	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—hematologic cancer	9.36e-05	0.000343	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisone—hematologic cancer	9.3e-05	0.000341	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—hematologic cancer	9.25e-05	0.000339	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—hematologic cancer	9.23e-05	0.000339	CcSEcCtD
Dihydrocodeine—Nausea—Prednisolone—hematologic cancer	9.23e-05	0.000339	CcSEcCtD
Dihydrocodeine—Pruritus—Dexamethasone—hematologic cancer	9.17e-05	0.000336	CcSEcCtD
Dihydrocodeine—Pruritus—Betamethasone—hematologic cancer	9.17e-05	0.000336	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—hematologic cancer	9.17e-05	0.000336	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.15e-05	0.000336	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—hematologic cancer	9.12e-05	0.000335	CcSEcCtD
Dihydrocodeine—Vomiting—Triamcinolone—hematologic cancer	9.09e-05	0.000333	CcSEcCtD
Dihydrocodeine—Rash—Triamcinolone—hematologic cancer	9.01e-05	0.000331	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—hematologic cancer	9.01e-05	0.00033	CcSEcCtD
Dihydrocodeine—Dermatitis—Triamcinolone—hematologic cancer	9e-05	0.00033	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—hematologic cancer	8.99e-05	0.00033	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisone—hematologic cancer	8.97e-05	0.000329	CcSEcCtD
Dihydrocodeine—Headache—Triamcinolone—hematologic cancer	8.95e-05	0.000328	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—hematologic cancer	8.93e-05	0.000327	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—hematologic cancer	8.9e-05	0.000327	CcSEcCtD
Dihydrocodeine—Diarrhoea—Betamethasone—hematologic cancer	8.87e-05	0.000325	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dexamethasone—hematologic cancer	8.87e-05	0.000325	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—hematologic cancer	8.82e-05	0.000323	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—hematologic cancer	8.67e-05	0.000318	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—hematologic cancer	8.66e-05	0.000318	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—hematologic cancer	8.58e-05	0.000315	CcSEcCtD
Dihydrocodeine—Dizziness—Dexamethasone—hematologic cancer	8.57e-05	0.000315	CcSEcCtD
Dihydrocodeine—Dizziness—Betamethasone—hematologic cancer	8.57e-05	0.000315	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—hematologic cancer	8.54e-05	0.000313	CcSEcCtD
Dihydrocodeine—Nausea—Triamcinolone—hematologic cancer	8.49e-05	0.000311	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—hematologic cancer	8.47e-05	0.000311	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.46e-05	0.000311	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—hematologic cancer	8.41e-05	0.000309	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—hematologic cancer	8.39e-05	0.000308	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—hematologic cancer	8.34e-05	0.000306	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—hematologic cancer	8.25e-05	0.000303	CcSEcCtD
Dihydrocodeine—Vomiting—Betamethasone—hematologic cancer	8.24e-05	0.000302	CcSEcCtD
Dihydrocodeine—Vomiting—Dexamethasone—hematologic cancer	8.24e-05	0.000302	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—hematologic cancer	8.24e-05	0.000302	CcSEcCtD
Dihydrocodeine—Rash—Dexamethasone—hematologic cancer	8.17e-05	0.0003	CcSEcCtD
Dihydrocodeine—Rash—Betamethasone—hematologic cancer	8.17e-05	0.0003	CcSEcCtD
Dihydrocodeine—Dermatitis—Dexamethasone—hematologic cancer	8.17e-05	0.0003	CcSEcCtD
Dihydrocodeine—Dermatitis—Betamethasone—hematologic cancer	8.17e-05	0.0003	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.15e-05	0.000299	CcSEcCtD
Dihydrocodeine—Headache—Dexamethasone—hematologic cancer	8.12e-05	0.000298	CcSEcCtD
Dihydrocodeine—Headache—Betamethasone—hematologic cancer	8.12e-05	0.000298	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—hematologic cancer	8.01e-05	0.000294	CcSEcCtD
Dihydrocodeine—Pruritus—Prednisone—hematologic cancer	7.99e-05	0.000293	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—hematologic cancer	7.94e-05	0.000291	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—hematologic cancer	7.93e-05	0.000291	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—hematologic cancer	7.9e-05	0.00029	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—hematologic cancer	7.87e-05	0.000289	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—hematologic cancer	7.85e-05	0.000288	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—hematologic cancer	7.78e-05	0.000285	CcSEcCtD
Dihydrocodeine—Diarrhoea—Prednisone—hematologic cancer	7.73e-05	0.000283	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—hematologic cancer	7.72e-05	0.000283	CcSEcCtD
Dihydrocodeine—Nausea—Dexamethasone—hematologic cancer	7.7e-05	0.000283	CcSEcCtD
Dihydrocodeine—Nausea—Betamethasone—hematologic cancer	7.7e-05	0.000283	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—hematologic cancer	7.64e-05	0.00028	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.62e-05	0.00028	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—hematologic cancer	7.55e-05	0.000277	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—hematologic cancer	7.5e-05	0.000275	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisone—hematologic cancer	7.47e-05	0.000274	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—hematologic cancer	7.46e-05	0.000274	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—hematologic cancer	7.34e-05	0.000269	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—hematologic cancer	7.28e-05	0.000267	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—hematologic cancer	7.28e-05	0.000267	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—hematologic cancer	7.26e-05	0.000266	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—hematologic cancer	7.22e-05	0.000265	CcSEcCtD
Dihydrocodeine—Vomiting—Prednisone—hematologic cancer	7.18e-05	0.000263	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—hematologic cancer	7.12e-05	0.000261	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—hematologic cancer	7.11e-05	0.000261	CcSEcCtD
Dihydrocodeine—Headache—Prednisone—hematologic cancer	7.07e-05	0.000259	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.05e-05	0.000259	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—hematologic cancer	7.02e-05	0.000257	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—hematologic cancer	6.99e-05	0.000256	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—hematologic cancer	6.98e-05	0.000256	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—hematologic cancer	6.73e-05	0.000247	CcSEcCtD
Dihydrocodeine—Nausea—Prednisone—hematologic cancer	6.71e-05	0.000246	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.68e-05	0.000245	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—hematologic cancer	6.68e-05	0.000245	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—hematologic cancer	6.49e-05	0.000238	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—hematologic cancer	6.46e-05	0.000237	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—hematologic cancer	6.46e-05	0.000237	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—hematologic cancer	6.25e-05	0.000229	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—hematologic cancer	6.24e-05	0.000229	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—hematologic cancer	6.04e-05	0.000222	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—hematologic cancer	6e-05	0.00022	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—hematologic cancer	5.95e-05	0.000218	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—hematologic cancer	5.94e-05	0.000218	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—hematologic cancer	5.91e-05	0.000217	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—hematologic cancer	5.84e-05	0.000214	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—hematologic cancer	5.78e-05	0.000212	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—hematologic cancer	5.61e-05	0.000206	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—hematologic cancer	5.61e-05	0.000206	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—hematologic cancer	5.59e-05	0.000205	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—hematologic cancer	5.57e-05	0.000204	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—hematologic cancer	5.56e-05	0.000204	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—hematologic cancer	5.53e-05	0.000203	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—hematologic cancer	5.4e-05	0.000198	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—hematologic cancer	5.25e-05	0.000192	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—hematologic cancer	5.2e-05	0.000191	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—hematologic cancer	5.15e-05	0.000189	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—hematologic cancer	5.15e-05	0.000189	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—hematologic cancer	5.12e-05	0.000188	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—hematologic cancer	4.85e-05	0.000178	CcSEcCtD
Dihydrocodeine—OPRM1—Signaling Pathways—TRH—hematologic cancer	2.41e-05	0.000619	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CMA1—hematologic cancer	2.41e-05	0.000619	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.41e-05	0.000618	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.38e-05	0.00061	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AGO2—hematologic cancer	2.36e-05	0.000606	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SPHK1—hematologic cancer	2.36e-05	0.000606	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LPAR1—hematologic cancer	2.34e-05	0.0006	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HDAC9—hematologic cancer	2.34e-05	0.0006	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HDC—hematologic cancer	2.33e-05	0.000598	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—H3F3B—hematologic cancer	2.31e-05	0.000594	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRB2—hematologic cancer	2.23e-05	0.000573	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CSF2—hematologic cancer	2.2e-05	0.000564	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDE4B—hematologic cancer	2.15e-05	0.000552	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CNR2—hematologic cancer	2.15e-05	0.000552	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF19—hematologic cancer	2.13e-05	0.000547	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CDA—hematologic cancer	2.13e-05	0.000546	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—JAK1—hematologic cancer	2.12e-05	0.000544	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PRKCG—hematologic cancer	2.12e-05	0.000544	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAC2—hematologic cancer	2.12e-05	0.000543	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DKK1—hematologic cancer	2.1e-05	0.000539	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT5B—hematologic cancer	2.08e-05	0.000535	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PC—hematologic cancer	2.05e-05	0.000526	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADCY7—hematologic cancer	2.02e-05	0.000519	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PHYH—hematologic cancer	2.01e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GMPS—hematologic cancer	2.01e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FTCD—hematologic cancer	2.01e-05	0.000515	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CSF2—hematologic cancer	2e-05	0.000512	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2RA—hematologic cancer	1.98e-05	0.000508	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.98e-05	0.000508	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GBA—hematologic cancer	1.98e-05	0.000508	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—XIAP—hematologic cancer	1.97e-05	0.000505	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PRKCG—hematologic cancer	1.93e-05	0.000494	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—JAK1—hematologic cancer	1.93e-05	0.000494	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SMARCA4—hematologic cancer	1.92e-05	0.000492	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SH2B3—hematologic cancer	1.92e-05	0.000492	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GZMB—hematologic cancer	1.91e-05	0.000489	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CTNNA1—hematologic cancer	1.86e-05	0.000477	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.85e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HSPB1—hematologic cancer	1.85e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL3—hematologic cancer	1.85e-05	0.000475	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.84e-05	0.000471	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SDC1—hematologic cancer	1.83e-05	0.000469	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTHLH—hematologic cancer	1.83e-05	0.000469	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.81e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2RA—hematologic cancer	1.8e-05	0.000461	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTGER4—hematologic cancer	1.78e-05	0.000457	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—LCK—hematologic cancer	1.77e-05	0.000455	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—H3F3A—hematologic cancer	1.74e-05	0.000446	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCZ—hematologic cancer	1.69e-05	0.000433	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.65e-05	0.000423	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PARP1—hematologic cancer	1.63e-05	0.000418	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.61e-05	0.000414	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.61e-05	0.000412	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—DCK—hematologic cancer	1.61e-05	0.000412	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.61e-05	0.000412	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FBXW7—hematologic cancer	1.6e-05	0.000412	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.58e-05	0.000406	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	1.57e-05	0.000404	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	1.57e-05	0.000404	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CBL—hematologic cancer	1.53e-05	0.000393	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HDC—hematologic cancer	1.52e-05	0.000391	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL3—hematologic cancer	1.52e-05	0.000389	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.5e-05	0.000385	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.5e-05	0.000385	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	1.5e-05	0.000384	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	1.49e-05	0.000383	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	1.47e-05	0.000378	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	1.47e-05	0.000376	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SYK—hematologic cancer	1.46e-05	0.000375	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	1.46e-05	0.000375	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	1.45e-05	0.000372	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	1.43e-05	0.000366	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.41e-05	0.000362	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT1—hematologic cancer	1.41e-05	0.000362	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	1.4e-05	0.000358	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CDA—hematologic cancer	1.39e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	1.39e-05	0.000357	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.37e-05	0.000352	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CA9—hematologic cancer	1.37e-05	0.000352	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.37e-05	0.000351	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.35e-05	0.000348	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PC—hematologic cancer	1.34e-05	0.000344	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	1.33e-05	0.000342	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	1.33e-05	0.00034	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRB2—hematologic cancer	1.32e-05	0.000338	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	1.32e-05	0.000338	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	1.32e-05	0.000338	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KITLG—hematologic cancer	1.3e-05	0.000333	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GBA—hematologic cancer	1.29e-05	0.000332	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.29e-05	0.000332	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.29e-05	0.000331	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.28e-05	0.000327	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.28e-05	0.000327	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TXN—hematologic cancer	1.28e-05	0.000327	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	1.27e-05	0.000325	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	1.26e-05	0.000324	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	1.26e-05	0.000322	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.25e-05	0.00032	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	1.24e-05	0.000319	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CD86—hematologic cancer	1.22e-05	0.000312	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	1.21e-05	0.00031	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.2e-05	0.000308	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HES1—hematologic cancer	1.2e-05	0.000308	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	1.19e-05	0.000306	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.18e-05	0.000304	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF1—hematologic cancer	1.18e-05	0.000302	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CSF2—hematologic cancer	1.18e-05	0.000302	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.17e-05	0.000299	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.17e-05	0.000299	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	1.16e-05	0.000298	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	1.16e-05	0.000298	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	1.16e-05	0.000298	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	1.15e-05	0.000295	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	1.14e-05	0.000293	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JAK1—hematologic cancer	1.14e-05	0.000292	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	1.14e-05	0.000292	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.14e-05	0.000292	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.1e-05	0.000283	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.07e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.07e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	1.06e-05	0.000273	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NUP214—hematologic cancer	1.06e-05	0.000272	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FHL2—hematologic cancer	1.06e-05	0.000271	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—hematologic cancer	1.05e-05	0.000271	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—hematologic cancer	1.05e-05	0.00027	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTR—hematologic cancer	1.04e-05	0.000267	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.04e-05	0.000267	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AGRN—hematologic cancer	1.04e-05	0.000266	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	1.03e-05	0.000263	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ENO2—hematologic cancer	1.02e-05	0.000262	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TSC2—hematologic cancer	1e-05	0.000257	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTT1—hematologic cancer	9.89e-06	0.000254	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMMR—hematologic cancer	9.81e-06	0.000252	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—IDH2—hematologic cancer	9.81e-06	0.000252	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SDC1—hematologic cancer	9.67e-06	0.000248	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	9.64e-06	0.000247	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	9.55e-06	0.000245	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	9.36e-06	0.00024	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FN1—hematologic cancer	9.25e-06	0.000237	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.22e-06	0.000237	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BAD—hematologic cancer	9.14e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	9.14e-06	0.000234	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	9.05e-06	0.000232	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ACP5—hematologic cancer	8.97e-06	0.00023	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CA9—hematologic cancer	8.97e-06	0.00023	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CD80—hematologic cancer	8.87e-06	0.000228	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.86e-06	0.000227	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	8.85e-06	0.000227	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KIT—hematologic cancer	8.85e-06	0.000227	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	8.85e-06	0.000227	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	8.7e-06	0.000223	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	8.48e-06	0.000217	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—IDH1—hematologic cancer	8.44e-06	0.000216	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	8.43e-06	0.000216	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.34e-06	0.000214	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.34e-06	0.000214	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TXN—hematologic cancer	8.34e-06	0.000214	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	8.32e-06	0.000213	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	8.24e-06	0.000212	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CD44—hematologic cancer	8.22e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NQO1—hematologic cancer	8.22e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	8.22e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	8.21e-06	0.000211	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.16e-06	0.000209	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.84e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	7.83e-06	0.000201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	7.78e-06	0.0002	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYCS—hematologic cancer	7.78e-06	0.0002	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	7.73e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	7.71e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.63e-06	0.000196	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.63e-06	0.000196	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	7.62e-06	0.000195	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	7.45e-06	0.000191	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.44e-06	0.000191	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	7.35e-06	0.000189	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NUP98—hematologic cancer	7.2e-06	0.000185	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	7.14e-06	0.000183	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	7e-06	0.00018	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.99e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.99e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	6.97e-06	0.000179	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NUP214—hematologic cancer	6.94e-06	0.000178	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—hematologic cancer	6.86e-06	0.000176	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTR—hematologic cancer	6.8e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.8e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	6.78e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	6.78e-06	0.000174	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ENO2—hematologic cancer	6.67e-06	0.000171	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.49e-06	0.000167	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	6.48e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.47e-06	0.000166	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	6.37e-06	0.000163	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SDC1—hematologic cancer	6.32e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—hematologic cancer	6.3e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOR1—hematologic cancer	6.3e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	6.3e-06	0.000162	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	6.24e-06	0.00016	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—hematologic cancer	6.23e-06	0.00016	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	6.2e-06	0.000159	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	6.07e-06	0.000156	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JUN—hematologic cancer	6.06e-06	0.000155	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	5.87e-06	0.000151	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	5.86e-06	0.00015	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	5.73e-06	0.000147	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	5.72e-06	0.000147	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EP300—hematologic cancer	5.59e-06	0.000143	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.57e-06	0.000143	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SRC—hematologic cancer	5.44e-06	0.000139	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CD44—hematologic cancer	5.38e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NQO1—hematologic cancer	5.38e-06	0.000138	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	5.29e-06	0.000136	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	5.24e-06	0.000134	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	5.23e-06	0.000134	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYCS—hematologic cancer	5.09e-06	0.000131	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.05e-06	0.00013	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	5.01e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—hematologic cancer	4.87e-06	0.000125	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	4.86e-06	0.000125	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.68e-06	0.00012	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	4.5e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.48e-06	0.000115	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.34e-06	0.000111	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.24e-06	0.000109	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	4.13e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.12e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.12e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	4.11e-06	0.000106	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—hematologic cancer	4.06e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—hematologic cancer	4e-06	0.000103	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.88e-06	9.97e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	3.83e-06	9.81e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—hematologic cancer	3.66e-06	9.39e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.64e-06	9.34e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.59e-06	9.2e-05	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	3.38e-06	8.67e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTEN—hematologic cancer	3.1e-06	7.95e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.06e-06	7.85e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—EP300—hematologic cancer	2.95e-06	7.58e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.84e-06	7.28e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.69e-06	6.9e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—hematologic cancer	2.66e-06	6.81e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.54e-06	6.52e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.34e-06	6.01e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.19e-06	5.61e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.03e-06	5.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—EP300—hematologic cancer	1.93e-06	4.96e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.79e-06	4.58e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.43e-06	3.67e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.17e-06	3e-05	CbGpPWpGaD
